These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 6298681

  • 1. Effect of cytotoxic drugs on the function of the hypothalamo-pituitary-adrenal axis.
    Pfreundschuh M, Gless KH, Dörken B, Vecsei P, Hunstein W.
    Oncology; 1983; 40(2):102-5. PubMed ID: 6298681
    [Abstract] [Full Text] [Related]

  • 2. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.
    Gutiérrez MA, García ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S.
    J Rheumatol; 1999 Feb; 26(2):277-81. PubMed ID: 9972958
    [Abstract] [Full Text] [Related]

  • 4. Thyroid hormone therapy modulates hypothalamo-pituitary-adrenal axis.
    Lizcano F, Rodríguez JS.
    Endocr J; 2011 Feb; 58(2):137-42. PubMed ID: 21263198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Megestrol acetate therapy and secondary adrenal suppression.
    Naing KK, Dewar JA, Leese GP.
    Cancer; 1999 Sep 15; 86(6):1044-9. PubMed ID: 10491532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypofunction of the stress axis in Sjögren's syndrome.
    Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 1998 Aug 15; 25(8):1508-14. PubMed ID: 9712092
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An acute injection of corticosterone increases thyrotrophin-releasing hormone expression in the paraventricular nucleus of the hypothalamus but interferes with the rapid hypothalamus pituitary thyroid axis response to cold in male rats.
    Sotelo-Rivera I, Jaimes-Hoy L, Cote-Vélez A, Espinoza-Ayala C, Charli JL, Joseph-Bravo P.
    J Neuroendocrinol; 2014 Dec 15; 26(12):861-9. PubMed ID: 25283355
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Dec 15; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.